OBJECTIVE: We assessed the safety and efficacy of a 1 a-day twice daily
rabeprazole-based triple therapy for Helicobacler pylori (H .pylon).
METHODS: H. pylori infected patients as confirmed by a rapid urease test
were ...
Background: Treatment regimens for Helicobacter pylori (H. pylori) usually combine an acid reducing agent (proton-pump inhibitor, H2-antagonist) with two or three antibiotics (macrolide, metronidazole, tetracycline, ...